ROIVW (Roivant Sciences) Total Assets: $5,708.69 Mil (As of Mar. 2026)


ROIVW Roivant Sciences Ltd ROIVW
55 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences Total Assets?

Roivant Sciences ROIVW -3.85% 55 Total Assets is $5,708.69 Mil as of Mar. 2026. GuruFocus rates ROIVW with a GF Score™ of 55/100. The stock has 7 warning signs investors should review.

Roivant Sciences's Total Assets for the quarter that ended in Mar. 2026 was $5,708.69 Mil.

During the past 12 months, Roivant Sciences's average Total Assets Growth Rate was 157.60% per year. During the past 3 years, the average Total Assets Growth Rate was 25.70% per year. During the past 5 years, the average Total Assets Growth Rate was 15.50% per year.

During the past 6 years, Roivant Sciences's highest 3-Year average Total Assets Growth Rate was 25.70%. The lowest was 1.60%. And the median was 10.80%.

Total Assets is connected with ROA %. Roivant Sciences's annualized ROA % for the quarter that ended in Mar. 2026 was 22.17%. Total Assets is also linked to Revenue through Asset Turnover. Roivant Sciences's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Roivant Sciences  (NAS:ROIVW) Total Assets Explanation

Total Assets is connected with ROA %.

Roivant Sciences's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=1211.976/( (5225.368+5708.687)/ 2 )
=1211.976/5467.0275
=22.17 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Roivant Sciences's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=2.52/( (5225.368+5708.687)/ 2 )
=2.52/5467.0275
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Roivant Sciences Total Assets Related Terms

Roivant Sciences Total Assets Historical Data

* Premium members only.

The historical data trend for Roivant Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences Total Assets Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial 2,585.13 2,389.60 7,222.48 5,436.94 5,708.69

Roivant Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,436.94 5,032.60 5,062.60 5,225.37 5,708.69
ROIVW
55GF Score
Roivant Sciences Ltd ROIVW
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roivant Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Roivant Sciences's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=5292.412+416.275
=5,708.69

Roivant Sciences's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=5292.412+416.275
=5,708.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $5,708.69 Mil mean?
Roivant Sciences (ROIVW) has a Total Assets of $5,708.69 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Roivant Sciences and its competitors.
Is Roivant Sciences' Total Assets too high?
Roivant Sciences' current Total Assets is $5,708.69 Mil. Overall, Roivant Sciences has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Roivant Sciences' Total Assets compare to INSM and INCY?
Roivant Sciences' Total Assets of $5,708.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Roivant Sciences and its competitors. Roivant Sciences's current Total Assets is $5,708.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roivant Sciences stock overvalued right now?
Roivant Sciences (ROIVW) has a current Total Assets of $5,708.69 Mil. The current Total Assets is $5,708.69 Mil. Roivant Sciences' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Roivant Sciences (ROIVW), the current Total Assets is $5,708.69 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
55GF Score

Get the complete analysis for ROIVW

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price